Bailong Chuangyuan(SH:605016) GUOTAI HAITONG SECURITIES·2026-01-23 05:05Investment Rating - The investment rating for the company is "Accumulate" [4][17]. Core Views - The company is expected to show significant revenue growth with a notable acceleration in net profit, indicating a high quality of growth and sustained potential for continued expansion [1]. - The financial forecast indicates a strong upward trend in both revenue and net profit over the next few years, with revenue projected to reach 13.79 billion yuan in 2025, representing a year-on-year increase of 19.8%, and net profit expected to reach 3.66 billion yuan, reflecting a year-on-year increase of 48.9% [3][10]. Financial Summary - Total revenue is forecasted to grow from 8.68 billion yuan in 2023 to 22 billion yuan in 2027, with annual growth rates ranging from 19.8% to 32.6% [3]. - Net profit attributable to the parent company is projected to increase from 1.93 billion yuan in 2023 to 6.37 billion yuan in 2027, with growth rates between 27.3% and 48.9% [3]. - Earnings per share (EPS) is expected to rise from 0.46 yuan in 2023 to 1.52 yuan in 2027 [3]. - The return on equity (ROE) is anticipated to improve from 12.8% in 2023 to 21.3% in 2027 [3]. Market Data - The company's target price has been raised to 31.90 yuan, up from a previous target of 30.16 yuan, reflecting a favorable valuation based on comparable company averages [4][10]. - The stock has shown a 52-week price range of 16.17 to 28.55 yuan, with a total market capitalization of 9.442 billion yuan [5]. Growth Drivers - The company is experiencing increased demand for its products, particularly high-margin resistant dextrin products, which are contributing to profit growth [10]. - The company is also expanding its production capacity and optimizing its product structure, which is expected to alleviate capacity constraints and enhance profitability [10]. - The introduction of high-margin customized products and the expansion into overseas markets are anticipated to drive future growth, particularly in the context of rising health-conscious consumer trends [10].